Detalhe da pesquisa
1.
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.
Clin Exp Dermatol
; 48(4): 379-381, 2023 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745578
2.
Exacerbation of acquired perforating dermatosis following SARS-CoV-2 vaccination.
J Eur Acad Dermatol Venereol
; 37(9): e1091-e1093, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37113011
3.
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Dermatol Ther
; 35(11): e15818, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097346
4.
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies.
Melanoma Res
; 33(6): 462-474, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788101
5.
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience.
J Clin Med
; 12(2)2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675481
6.
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer.
Front Med (Lausanne)
; 9: 959289, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36844955
7.
A case of treatment-refractory psoriasis as the first manifestation of an HIV-infection.
Ital J Dermatol Venerol
; 159(1): 68-69, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015571
8.
Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk.
Expert Opin Biol Ther
; 24(4): 217-219, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557408